Breastfeeding for longer than 6 months can lower breast cancer mortality risk

A new study of women 20 years after undergoing surgery for primary breast cancer shows that breastfeeding for longer than 6 months is associated with a better survival rate. Among breast cancer survivors who breastfed for >6 months, both breast cancer mortality and overall mortality risk were less after 20 years, according to the study published in Breastfeeding Medicine, the official journal of the Academy of Breastfeeding Medicine published by Mary Ann Liebert, Inc., publishers.

In "Breastfeeding Associated with Reduced Mortality in Women with Breast Cancer (http://online.liebertpub.com/doi/full/10.1089/bfm.2015.0094)," Margaretha Lööf-Johanson, MD, Lars Brudin, MD, PhD, and Marie Sundquist, MD, PhD, University of Linkoping, and County Hospital, Kalmar, Sweden, and Carl Edvard Rudebeck, MD, PhD, University of Tromso, Norway, examined the link between lifetime breastfeeding history and both breast cancer-specific and overall survival among women treated for breast cancer who had lived long enough for other causes of death to contribute substantially to mortality.

"This study confirms that the long-term maternal health benefits of breastfeeding are not only preventative in nature, but that it also has the capacity to reduce the severity of breast cancer," says Arthur I. Eidelman, MD, Editor-in-Chief of Breastfeeding Medicine.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Scientists map cancer mutations in EGFR gene, revealing drug resistance paths